We are live on ! Find out more
KIC

Keating Investment Counselors Portfolio holdings

AUM $364M
1-Year Est. Return 22.11%
This Fund
S&P 500
This Quarter Est. Return
+5.66%
1 Year Est. Return
+22.11%
3 Year Est. Return
+43.74%
5 Year Est. Return
+59.25%
10 Year Est. Return
+177.63%
AUM
$232M
AUM Growth
+$21.4M
Cap. Flow
+$9.98M
Cap. Flow %
4.3%
Top 10 Hldgs %
43.17%
Holding
68
New
5
Increased
5
Reduced
45
Closed
3

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$4.53M
2
LW icon
Lamb Weston
LW
+$2.88M
3
SPHQ icon
Invesco S&P 500 Quality ETF
SPHQ
+$1.27M
4
HD icon
Home Depot
HD
+$1.24M
5
INTC icon
Intel
INTC
+$1.07M

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.99%
2 Healthcare 18.77%
3 Industrials 14.49%
4 Consumer Discretionary 8.17%
5 Communication Services 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STIP icon
1
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$22.2M 9.55%
+224,488
New +$22.2M
HD icon
2
Home Depot
HD
$339B
$11.6M 4.98%
55,792
-6,135
-10% -$1.24M
LW icon
3
Lamb Weston
LW
$7.29B
$9.98M 4.3%
149,823
-41,913
-22% -$2.88M
VZ icon
4
Verizon
VZ
$197B
$8.8M 3.79%
164,752
+3,727
+2% +$197K
LMT icon
5
Lockheed Martin
LMT
$135B
$8.51M 3.66%
24,594
-963
-4% -$311K
JNJ icon
6
Johnson & Johnson
JNJ
$613B
$8.42M 3.62%
60,929
-6,796
-10% -$903K
CVS icon
7
CVS Health
CVS
$134B
$8.38M 3.61%
106,448
+10,663
+11% +$762K
INTC icon
8
Intel
INTC
$459B
$7.78M 3.35%
164,612
-21,903
-12% -$1.07M
MRK icon
9
Merck
MRK
$316B
$7.34M 3.16%
108,485
-5,905
-5% -$376K
TFC icon
10
Truist Financial
TFC
$63.4B
$7.33M 3.16%
151,037
-8,895
-6% -$456K
PM icon
11
Philip Morris
PM
$292B
$7.14M 3.08%
87,629
+12,130
+16% +$996K
B
12
Barrick Mining
B
$62.6B
$6.95M 2.99%
627,100
-15,250
-2% -$170K
HON icon
13
Honeywell
HON
$78.2B
$6.9M 2.97%
45,916
-1,377
-3% -$195K
CALM icon
14
Cal-Maine
CALM
$4.08B
$6.62M 2.85%
137,120
-5,195
-4% -$248K
PG icon
15
Procter & Gamble
PG
$338B
$5.13M 2.21%
61,668
-2,954
-5% -$242K
KMB icon
16
Kimberly-Clark
KMB
$35.7B
$4.96M 2.13%
43,613
-2,100
-5% -$235K
KLAC icon
17
KLA
KLAC
$239B
$4.95M 2.13%
486,940
-31,700
-6% -$347K
MMM icon
18
3M
MMM
$91.4B
$4.95M 2.13%
28,101
-1,944
-6% -$335K
TMO icon
19
Thermo Fisher Scientific
TMO
$212B
$4.73M 2.04%
19,385
-1,310
-6% -$301K
KO icon
20
Coca-Cola
KO
$374B
$4.72M 2.03%
102,212
-9,212
-8% -$421K
PEP icon
21
PepsiCo
PEP
$191B
$4.61M 1.98%
41,199
-3,388
-8% -$384K
XOM icon
22
ExxonMobil
XOM
$643B
$4.47M 1.92%
52,529
-2,200
-4% -$180K
UPS icon
23
United Parcel Service
UPS
$90.8B
$4.35M 1.87%
37,252
-1,820
-5% -$214K
AZN icon
24
AstraZeneca
AZN
$245B
$4.28M 1.84%
54,118
-59,925
-53% -$4.53M
DIS icon
25
Walt Disney
DIS
$170B
$4.19M 1.8%
35,815
-3,144
-8% -$350K

Similar funds

Keating Investment Counselors's Q3 2018 Portfolio in Review

As of Q3 2018, Keating Investment Counselors held 68 positions worth $232M, up 10% from $211M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Keating Investment Counselors deployed $9.98M of net new capital in Q3 2018, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 224,488 shares worth $22.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $4.53M trimmed.

  • Keating Investment Counselors's largest Q3 2018 buy was iShares 0-5 Year TIPS Bond ETF: 224,488 shares worth $22.2M.
  • Keating Investment Counselors added most to Philip Morris in Q3 2018, an estimated $996K increase.
  • Keating Investment Counselors's biggest Q3 2018 reduction was AstraZeneca, cutting an estimated $4.53M.
  • Keating Investment Counselors fully exited ChampionX in Q3 2018, selling an estimated $566K.
  • Keating Investment Counselors's ten largest holdings make up 43% of its $232M portfolio in Q3 2018.
  • Keating Investment Counselors opened 5 new positions and closed 3 in Q3 2018.
  • Keating Investment Counselors's portfolio value rose 10% quarter-over-quarter to $232M.

Based on Keating Investment Counselors's 13F filing for Q3 2018, filed 30 Oct 2018.